|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.474 SEK | -0.11% |
|
-3.27% | -9.37% |
| Apr. 16 | Mendus AB Announces Board Changes | CI |
| Mar. 27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
Mendus AB (publ) announced that at its Annual General Meeting to be held on 17 May 2024, Christine Lind and Andrea van Elsas have declined re-election.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.37% | 43.59M | |
| +1.77% | 42.75B | |
| +47.70% | 41.61B | |
| +12.24% | 41.34B | |
| -8.83% | 26.59B | |
| +7.44% | 25.49B | |
| -23.01% | 18.12B | |
| +30.56% | 12.24B | |
| -1.82% | 11.76B | |
| +8.35% | 11B |
MENDUS AB 
